Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inovox is a Polish pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) specializing in the production of lozenges, medical devices, and food supplements. The company operates a state-of-the-art manufacturing facility in Rzgów, Poland, which is equipped with advanced technology for the production of hard-boiled lozenges and sprays. Inovox is best known for its proprietary brand, Inovox Express, which provides symptomatic relief for sore throats using active ingredients like lidocaine and antiseptics. Beyond its own brands, the company provides comprehensive CDMO services, including formulation development, manufacturing, and packaging for global pharmaceutical partners. Inovox focuses on high-quality production standards, maintaining GMP certification to serve international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on inovoX.